Word: phasing
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
Even in this dreary phase, the computer industry has a few bright lights. The most dependable star right now is Houston-based Compaq, which makes IBM- compatible desktop and portable machines. Started less than eight years ago, Compaq is expected to reach sales of $3 billion in 1989. Last week the company did it again. Compaq introduced its eagerly awaited LTE, a laptop machine that packs all the power of a desktop computer into a package small enough to fit into a briefcase. The notebook-size machine has a standard keyboard and an easy-to-read backlit screen. Most important...
...told, the computer industry is entering a shake-out phase, in which slowing growth will force some companies to restructure or combine with healthier partners. Instead of the robust annual sales growth of 15% to 20% that the industry enjoyed in the early 1980s, computer revenues will expand an estimated 6% to 8% during the next few years. That pace would delight most industrialists, but among computer makers it represents an abrupt comedown. Profits are being squeezed even more. Last week the world's No. 1 and No. 2 computer makers announced sharply lower earnings during the most recent quarter...
Basically, the interview consists of twosegments. In the first phase, the employer willprobably try to determine your interest in thejob, your qualifications, and whether yourinterests and those of the company are compatible.In the second phase, she will usually give you anopportunity to ask questions. Necessarily, thefirst phase is the longer...
...Commerce subcommittee voted unanimously last week to adopt California's strict limits for the 1990s as the law of the land. The measure, which seemed certain to win House approval, would cut existing levels of tail-pipe pollutants as much as 60% from 1994 to 1996 and could phase out much of the remainder by 2006. The Senate is considering an even stronger bill...
Some researchers raise serious doubts about the methodology of guerrilla drug tests. Project Inform is strongly criticized for bypassing an initial phase to establish Compound Q's safety before proceeding to larger, therapeutic dosages and for not having the trials reviewed by an external monitoring group. Says Jere Goyan, dean of the University of California at San Francisco School of Pharmacy and a former FDA commissioner: "If you get people taking these drugs willy-nilly around the country, you'll lose valuable information, and it will be at the expense of future patients...